Dermatology-inspired CRISPR-based gene editing for keratinocyte repair in inherited skin disorders: a proof-of-concept study

Project Abstract

Dermatology-inspired CRISPR-based gene editing was employed to repair keratinocytes in inherited skin disorder models, aiming to establish a proof-of-concept for gene-corrected cell therapy and pave the way for durable, patient-specific treatments. The study integrates multidisciplinary approaches spanning molecular genetics, epidermal biology, and translational dermatology to address the fundamental challenges of precision editing in cutaneous tissues. We designed targeted CRISPR-CNP (CRISPR-Cas9 with optimized nickase and base editing variants) strategies to correct pathogenic mutations in keratinocyte lines derived from patient samples, followed by rigorous off-target assessment using unbiased genome-wide methods and in silico prediction to ensure genomic integrity. Primary human keratinocytes were cultured in defined serum-free conditions and subjected to delivery of CRISPR-Cas9 ribonucleoprotein complexes paired with single-guide RNAs specific to the disease-causing loci. Efficiency of on-target editing was quantified by deep sequencing, while restoration of normal protein expression and keratinocyte differentiation markers was evaluated through immunocytochemistry, flow cytometry, and Western blot analyses. To ascertain functional competence, edited keratinocytes underwent organotypic skin culture to recapitulate stratified epidermal architecture, and epidermal barrier function was assessed via transepidermal water loss measurements and impedance readings. We observed robust on-target correction frequencies with minimal indel formation and negligible off-target edits at predicted loci, accompanied by restored expression of mutant-replaced proteins to levels comparable with healthy controls. Edited keratinocytes demonstrated normal proliferation rates, preserved differentiation trajectories, and competent formation of a multi-layered, structurally cohesive epidermis in organotypic models. Importantly, corrected cells showed improved wound-healing dynamics in scratch assays and enhanced resistance to pathogenic insults in pathogen challenge experiments, indicating functional restoration beyond molecular correction. The study also explored delivery modalities, comparing electroporation, lipid nanoparticles, and viral vectors, with a strong preference for non-viral, transient delivery to minimize genomic risk. A comprehensive safety package was developed, including immunogenicity profiling, cytokine secretion assays, and long-term genomic stability monitoring under serial passaging. The translational potential was evaluated through ex vivo human skin graft experiments and a framework for autologous cell therapy manufacturing, emphasizing scalability, regulatory compliance, and ethical considerations. Limitations include the challenge of achieving durable engraftment in vivo, potential mosaicism of edits within heterogeneous keratinocyte populations, and the need for extended longitudinal studies in clinically relevant models. Nevertheless, the findings provide compelling evidence that precise CRISPR-based correction in patient-derived keratinocytes can restore key molecular and functional phenotypes of healthy skin, offering a viable proof-of-concept pathway toward curative therapies for inherited dermatologic disorders. Collectively, this work lays foundational groundwork for translating genome editing in skin into safe, effective, and personalized regenerative strategies.

Project Overview

What This Project Is About

---

A simple, patient-friendly look at using gene editing to fix skin cells so inherited skin problems can be repaired, using ideas inspired by dermatology. The project tests a proof-of-concept approach with keratinocytes (the main cells in the outer skin layer) to see if targeted edits can correct disease-causing errors and improve skin cell function.

---

---

The Problem It Addresses

---

Inherited skin disorders are often caused by genetic mistakes that weaken skin integrity and healing. Traditional therapies manage symptoms but don’t fix the root cause. This project explores a precise, targeted way to correct those genetic errors in skin cells to restore normal function.

---

---

Objectives of the Project

---

1. Identify a specific genetic defect common in a selected inherited skin disorder.
2. Design a safe, targeted method to correct the defect in keratinocytes.
3. Demonstrate in a controlled setting that edited cells show improved skin-function markers.
4. Assess potential off-target effects and safety considerations.
5. Evaluate feasibility and limitations for future steps toward clinical use.

---

---

What You Will Do Step by Step

---

1) Review background literature to choose a suitable gene target. 2) Develop a simple, ethical lab plan using non-clinical skin cell models. 3) Perform gene-editing simulations or bench tests in a controlled environment. 4) Measure markers of skin cell health and repair. 5) Analyze data for evidence of improved function and safety signals. 6) Summarize findings and discuss next steps and challenges.

---

---

Expected Outcome

Clear evidence that a targeted gene edit can restore key skin cell functions in a model system, with an assessment of safety and practical next steps toward further development.